Search

Author/Creator Pelling, K.

1. A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours. Issue 16 (November 2015)

Authors:
Suder, A.; Ang, J.E.; Kyle, F.; Harris, D.; Rudman, S.; Kristeleit, R.; Solca, F.; Uttenreuther-Fischer, M.; Pemberton, K.; Pelling, K.; Schnell, D.; de Bono, J.; Spicer, J.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 16(2015:Nov.)
Page Start:
2275
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search